Filing Details
Vivani Medical, Inc. (NASDAQ:VANI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:VANI
Vivani Medical, Inc. (VANI) Files Quarterly Report for Q0
Vivani Medical, Inc. (NASDAQ:VANI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 12, 2026.
At publication ·
What changed
Vivani Medical, Inc. (NASDAQ:VANI) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Vivani Medical filed its quarterly report (Form 10-Q) with the SEC on November 12, 2026.
- The healthcare company's stock trades at $1.13 with a market capitalization of $82.7 million.
- The 10-Q contains unaudited financial statements and management commentary on business performance and emerging risks.
Market Context
Vivani Medical, Inc.'s stock currently trades at $1.13 with a market capitalization of $82.7M.
The 10-Q provides Vivani Medical, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Vivani Medical, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VANI Stock Page
Frequently Asked Questions
Where can I read VANI's SEC filings?
Browse all filings on our VANI SEC filings page.
What types of SEC filings does Vivani Medical, Inc. file?
Public companies like Vivani Medical, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.